MiR-92a: at the heart of lipid-driven endothelial dysfunction.
From the Department of Medical Biochemistry, Experimental Vascular Biology, Academic Medical Center, Amsterdam, The Netherlands (M.P.J.d.W., E.L.); and Institute for Cardiovascular Prevention (IPEK), Ludwig Maximilians University, Munich, Germany (E.L.).
Menno P J
MP
de Winther
Esther
E
Lutgens
D000818:Animals; D050197:Atherosclerosis / Q000235:genetics* / Q000517:prevention & control*; D015536:Down-Regulation / Q000235:genetics*; D004730:Endothelium, Vascular / Q000378:metabolism*; D006801:Humans; D008297:Male; D035683:MicroRNAs / Q000037:antagonists & inhibitors* / Q000235:genetics*
D035683:MicroRNAs; C541873:Mirn92 microRNA, mouse
Editorials; antagomir-92a; atherosclerosis; endothelium; oxidized low-density lipoprotein